Civic Intelligence

Cancer Research Collaboration Inc.

990EZ • Fiscal year 2012 • EIN 46-1057568

Jan 01, 2012 to Dec 31, 2012

Anaheim, CA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

98th percentile

4.92x

Higher debt load relative to assets than 98% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Liabilities / Revenue

99th percentile

4.92x

Higher debt load relative to revenue than 99% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Net Margin

2nd percentile

-392%

Higher net margin than 2% of similar nonprofits.

2012 filings • 501(c)3 • <$500k nonprofits • Source year 2012

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2012

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2012

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2012

Assets

$4,086

No earlier filing loaded for comparison.

Net Assets

-

No earlier filing loaded for comparison.

Liabilities

$20,100

No earlier filing loaded for comparison.

Revenue

$4,086

No earlier filing loaded for comparison.

Expenses

$20,100

No earlier filing loaded for comparison.

Net Income

-$16,014

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$3.0M$2.0M$1.0M$0-$1.0MAssets 2012: $4,086Liabilities 2012: $20,1002012Assets 2013: $35,217Liabilities 2013: $314,771Net Assets 2013: -$279,5542013Assets 2014: $31,762Liabilities 2014: $297,177Net Assets 2014: -$265,4152014Assets 2015: $19,062Liabilities 2015: $411,510Net Assets 2015: -$392,4482015Assets 2016: $372,916Liabilities 2016: $688,395Net Assets 2016: -$315,4792016Assets 2017: $264,752Liabilities 2017: $530,269Net Assets 2017: -$265,5172017Assets 2018: $2,777,018Liabilities 2018: $1,524,579Net Assets 2018: $1,252,4392018Assets 2019: $1,545,255Liabilities 2019: $293,010Net Assets 2019: $1,252,2452019Assets 2020: $1,551,579Liabilities 2020: $269,225Net Assets 2020: $1,282,3542020Assets 2021: $1,097,037Liabilities 2021: $54,654Net Assets 2021: $1,042,3832021Assets 2022: $1,171,633Liabilities 2022: $154,654Net Assets 2022: $1,016,9792022Assets 2023: $1,116,558Liabilities 2023: $200,000Net Assets 2023: $916,5582023Assets 2024: $1,195,471Liabilities 2024: $101,610Net Assets 2024: $1,093,8612024

Highlighted filing

2012

Assets$4,086
Liabilities$20,100
Net Assets-

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$3.0M$2.0M$1.0M$0-$1.0MRevenue 2012: $4,086Expenses 2012: $20,100Net Income 2012: -$16,0142012Revenue 2013: $276,259Expenses 2013: $539,799Net Income 2013: -$263,5402013Revenue 2014: $616,841Expenses 2014: $602,702Net Income 2014: $14,1392014Revenue 2015: $589,108Expenses 2015: $716,141Net Income 2015: -$127,0332015Revenue 2016: $1,046,951Expenses 2016: $969,982Net Income 2016: $76,9692016Revenue 2017: $2,054,196Expenses 2017: $2,004,234Net Income 2017: $49,9622017Revenue 2018: $2,055,057Expenses 2018: $1,994,676Net Income 2018: $60,3812018Revenue 2019: $1,740,972Expenses 2019: $1,741,166Net Income 2019: -$1942019Revenue 2020: $66,695Expenses 2020: $36,586Net Income 2020: $30,1092020Revenue 2021: $11,003Expenses 2021: $109,403Net Income 2021: -$98,4002021Revenue 2022: $213,380Expenses 2022: $238,786Net Income 2022: -$25,4062022Revenue 2023: $151,199Expenses 2023: $302,509Net Income 2023: -$151,3102023Revenue 2024: $183,281Expenses 2024: $5,978Net Income 2024: $177,3032024

Highlighted filing

2012

Revenue$4,086
Expenses$20,100
Net Income-$16,014
Filing Detail Status

This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview

Mission

To conduct and fund scientific research for cancer and various medical research projects and clinical studies.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings